|
|
|
|
| 专题 |
最后回覆 |
昵称 |
内容 |
| 信达生物制药 |
2020-07-15T11:12 |
财经茄呢啡 |
信达生物（1801）旗下PD-1药物信迪利单抗为公司去年带来10亿人民币巨额收入，市场憧憬相关药物的销售潜力。 |
|
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window